Search clinical trials for: Bempegaldesleukin
Total 18 results
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Canada
-
Nektar TherapeuticsRecruiting
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States, Spain, Japan, India, Israel, Korea, Republic of, Taiwan, Australia, Puerto Rico, Argentina, Romania, Canada, Germany, Russian Federation, Mexico, Ukraine, Poland, Czechia, Hungary
-
Nektar TherapeuticsMerck Sharp & Dohme LLC; SFJ Pharmaceuticals, Inc.TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States, Austria, Greece, Italy
-
Nektar TherapeuticsTerminatedMelanoma | Sarcoma | Renal Cell Carcinoma | Colorectal Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Merkel Cell CarcinomaUnited States
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Nektar TherapeuticsCompleted
-
Bristol-Myers SquibbNektar TherapeuticsTerminatedEwing Sarcoma | Ependymoma | Medulloblastoma | Neuroblastoma | Rhabdomyosarcoma | High-grade Glioma | Leukemia and Lymphoma | Miscellaneous Brain Tumors | Miscellaneous Solid Tumors | Relapsed, Refractory Malignant NeoplasmsUnited States, Australia, France, Germany, Italy, Spain
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Nektar TherapeuticsBristol-Myers SquibbCompletedNeoplasm Metastasis | Urinary Bladder NeoplasmUnited States, Spain, United Kingdom, Belgium, Canada, Australia, France, Italy, Greece, Germany, Portugal, Argentina, Israel, Russian Federation, Turkey, Mexico, Finland, Netherlands
-
University of Wisconsin, MadisonNektar TherapeuticsTerminatedHead and Neck CancerUnited States
-
Nektar TherapeuticsBristol-Myers SquibbCompletedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast CancerUnited States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedRenal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States, Argentina, Brazil, Australia, Singapore, New Zealand, Russian Federation, Mexico, Peru, Chile